European regulators had major concerns over the quality of early batches of Pfizer's Covid vaccine
Updated: Oct 31, 2022
Major concerns were raised about the quality of early batches of Pfizer's coronavirus vaccine, leaked documents from the EU's medical regulator have revealed.
Scientists charged with checking the chemicals sent to the bloc for approval last year found doses were of a lower standard than the US drugmaker had promised.
Comments